What technology area does this patent fall under?

Primary CPC classification C07D405/14. Mapped technology areas include Chemistry & Metallurgy.

When was this patent published?

Publication date Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.

What related patents are in patentsdb?

We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).

Itraconazole analogs and use thereof

US11028078B2 · US · B2

Patent metadata
Field	Value
Publication number	US-11028078-B2
Application number	US-201816152008-A
Country	US
Kind code	B2
Filing date	Oct 4, 2018
Priority date	Sep 7, 2011
Publication date	Jun 8, 2021
Grant date	Jun 8, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

Title
What the patent document calls the invention.
Abstract
A short plain-language summary of the technical disclosure.
Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
Key dates
Filing, priority, publication, and grant dates set the timeline.
First independent claim
The legal scope of protection — read this for what is actually claimed.
CPC / IPC classifications
Technology tags used to group this patent with similar filings.
Citations and related patents
Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are Itraconazole analogs. Also provided herein are methods of inhibition of Hedgehog pathway, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, angiogenesis and treatment of disease with Itraconazole analogs.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound selected from: Compund Structure Number 214 215 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 2. A pharmaceutical composition comprising an effective amount of a compound according to claim 1 , and a pharmaceutically acceptable carrier.

Assignees

Univ Johns Hopkins

Inventors

Classifications

A61K31/496
Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin · CPC title
C07D405/14Primary
containing three or more hetero rings · CPC title
A61K31/506
not condensed and containing further heterocyclic rings · CPC title

Patent family

Related publications grouped by family.

View patent family 65229267

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11028078B2 cover?: Provided herein are Itraconazole analogs. Also provided herein are methods of inhibition of Hedgehog pathway, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, angiogenesis and treatment of disease with Itraconazole analogs.
Who is the assignee on this patent?: Univ Johns Hopkins
What technology area does this patent fall under?: Primary CPC classification C07D405/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?: Publication date Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?: We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).